Industry Advisory Council
Jana Stoudemire – Co-Chair
Jana Stoudemire joined the UMDF Board of Trustees on January 26, 2022.
As the Commercial Innovation Strategy Lead for Axiom Space, Jana is responsible for identifying new business opportunities for biomedical and technology research and in space manufacturing applications on the world’s first commercial space station. In addition to a strong technical background, Jana has a career history marked by successful identification of new business opportunities for private and public healthcare companies, along with product development and global commercialization of some of the most innovative healthcare technologies. She transitioned from pharma to lead life science research in microgravity as part of the team managing the International Space Station U.S. National Laboratory (ISS-NL), and envisions a future where the definition of ‘global’ will expand to include a robust commercial space economy in low Earth orbit (LEO) 250 miles up.
Jana is a member of the National Academies of Sciences, Engineering, and Medicine Committee on Biological and Physical Sciences in Space, Regenerative Medicine Manufacturing Society member, a WOMEN In Advanced Therapies (WIAT) leadership mentor, and past New Organ Alliance Oversight Committee Member, along with co-chair of the Microgravity Enabling Technology Committee.
Jana resides in Solana Beach, California, and is a proud mother of adult twins, Jack and McKenna. Jana’s son, Jack, received a mito diagnosis by muscle biopsy as a child. Since his diagnosis, she has been an appreciative advocate and strong supporter of the UMDF initiatives for patients and families.
Matthew Klein, MD, MS, FACS • Co-chair
Dr. Matthew Klein accepted the position of co-chair to the UMDF’s Industry Advisory Council (IAC) in 2020.
Dr. Klein is the CEO and President of PTC Therapeutics, Inc. Prior to joining PTC, Dr. Klein was CEO and Chief Medical of BioElectron Technology Corporation, a biotechnology company focused on development of redox active small molecules for mitochondrial disease and related disorders of oxidative stress. Prior to joining BioElectron, Dr. Klein was the Auth-Washington Research Foundation Chair of Restorative Burn Surgery at the University of Washington. Dr. Klein completed his undergraduate degree at the University of Pennsylvania where he graduated summa cum laude and Phi Beta Kappa, and received his MD degree with honors from Yale University.